Immunotherapy Company Enlivex Secures $21M Funding to Expand Rain Token Holdings
The pharmaceutical company reports purchasing 3 billion Rain tokens at a discounted rate while securing the right to buy additional billions of tokens at reduced prices through the end of next year.
Through a debt financing arrangement, immunotherapy developer Enlivex has successfully secured $21 million to acquire an additional 3 billion tokens from the prediction market platform Rain.
The company announced on Tuesday that it had activated an option to buy another 3 billion Rain (RAIN) tokens this past Sunday at a discounted rate of 62% for a total of $10 million, while simultaneously extending its purchase option for an additional 272.1 billion RAIN tokens at the same discounted price through December 2027. New York-based asset management firm The Lind Partners provided the debt financing.
We are continuing to execute our prediction markets treasury strategy, and we are pleased that Lind provided us with substantial capital, allowing us to continue the execution of our operating plan, as well as to acquire approximately three billion additional RAIN tokens.
Shai Novik, Enlivex executive chair
While Enlivex's primary business involves developing cell therapy solutions for knee osteoarthritis, the firm has joined a growing number of non-crypto companies acquiring cryptocurrencies with the goal of bolstering their balance sheets and appealing to a broader investor base.
Additionally, the company announced authorization of a $20 million share buyback program, designed to increase shareholder value.
Enlivex's RAIN token treasury value is intrinsically linked to Rain's decentralized prediction market platform, which features an automatic 2.5% fee mechanism that buys back and burns RAIN tokens, designed to improve the token's supply-demand economics.
RAIN token, Envilex shares trade mostly flat
Following Enlivex's announcement, the Rain token climbed 7% to reach $0.009 before experiencing a slight decline to $0.0088, remaining essentially unchanged over the previous 24 hours with just a 0.3% increase, based on CoinGecko data.
Enlivex (ENVL) shares similarly remained relatively flat throughout Tuesday's trading session, closing the day with a 0.9% decline at $1.10, though the stock experienced a 4.5% uptick during after-hours trading, climbing to $1.15.
Operating on the Ethereum Layer-2 Arbitrum network, Rain is positioned among the top 10 prediction market platforms when measured by total value locked and fees generated during the past seven days, according to data from DeFiLlama.
Prediction markets have emerged as one of the most popular use cases in the cryptocurrency space, with trading volumes surging more than 1,200% from $23.3 billion between February 2025 and February 2026.
Nevertheless, the market remains largely controlled by Kalshi and Polymarket, which together represent more than 80% of all trading volumes.